| Oct 16 |
Wave stock soars 38% on positive data for AATD therapy WVE-006
|
| Oct 16 |
Wave Life Sciences (WVE): Advancing Gene Therapy for Duchenne Muscular Dystrophy
|
| Oct 16 |
Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
|
| Oct 16 |
Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024
|
| Oct 16 |
Wave sees RNA editing validation in early trial results
|
| Oct 11 |
GSK Bought More Shares of Biotech Wave Life Sciences
|
| Oct 11 |
How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71%
|
| Oct 9 |
WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ...
|
| Oct 3 |
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics
|
| Oct 1 |
Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
